Furthermore, compared with model groups, LPD remarkably decreased the levels of p-JAK 2, p-STAT 3, cyclin D1, and Bcl-2 in a dose-dependent manner. The gene discussed is BCL2; the disease is disseminated peritoneal leiomyomatosis.